0001179110-20-009172.txt : 20200819 0001179110-20-009172.hdr.sgml : 20200819 20200819165216 ACCESSION NUMBER: 0001179110-20-009172 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200817 FILED AS OF DATE: 20200819 DATE AS OF CHANGE: 20200819 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hurley Ariel CENTRAL INDEX KEY: 0001769740 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37359 FILM NUMBER: 201117584 MAIL ADDRESS: STREET 1: C/O BLUEPRINT MEDICINES CORPORATION STREET 2: 45 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Blueprint Medicines Corp CENTRAL INDEX KEY: 0001597264 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 45 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-374-7580 MAIL ADDRESS: STREET 1: 45 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 edgar.xml FORM 4 - X0306 4 2020-08-17 0 0001597264 Blueprint Medicines Corp BPMC 0001769740 Hurley Ariel C/O BLUEPRINT MEDICINES CORPORATION 45 SIDNEY STREET CAMBRIDGE MA 02139 0 1 0 0 Principal Accounting Officer Common Stock 2020-08-17 4 M 0 700 1.87 A 10684 D Common Stock 2020-08-17 4 S 0 700 75 D 9984 D Stock Option (Right to Buy) 1.87 2020-08-17 4 M 0 700 0 D 2024-10-08 Common Stock 700 9954 D Effected pursuant to a trading plan adopted on March 17, 2020 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. This option was granted on October 8, 2014. This option vested with respect to 25% of the shares underlying the option on September 15, 2015 and vested as to an additional 1/48th of the shares underlying the option each month thereafter. /s/ Christopher Frankenfield, Attorney-in-Fact 2020-08-19